Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Share-based Compensation (2023 - 2025)

Onconetix (ONCO) has disclosed Share-based Compensation for 2 consecutive years, with $340425.0 as the latest value for Q4 2024.

  • On a quarterly basis, Share-based Compensation rose 245.48% to $340425.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $450300.0, a 36.55% increase, with the full-year FY2024 number at $438653.0, up 33.02% from a year prior.
  • Share-based Compensation was $340425.0 for Q4 2024 at Onconetix, up from $58000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $340425.0 in Q4 2024 to a low of -$234001.0 in Q4 2023.